Boston-based patent expert Jeffrey Jacobstein and Washington DC-based Erika Harmon Arner , Anand Sharma and PTAB trial expert Joshua Goldberg lead Finnegan, Henderson, Farabow, Garrett & Dunner LLP‘s team, which is described as ‘a powerhouse for all IP matters’. The firm handles the full spectrum of IP services for its national and international client base, notably representing AstraZeneca in patent prosecution and strategic counseling matters, with Washington DC’s Jill MacAlpine playing a key role. DC’s Adriana L. Burgy leads on cross-jurisdictional, environmentally significant work for BASF. The team also handles complex matters for clients in the technological and electrical sectors, an example being its current work assisting Alibaba on cloud computing, AI and blockchain-related patent drafting and prosecution work, as well as advising on high-value PTAB matters. In the Atlanta office, specialist in mechanical, electrical, computer and medical device technologies Benjamin Saidman and the ‘super smart’ Kara Specht are key up-and-coming names. Palo Alto’s Arpita Bhattacharyya has a developing specialism in post-grant proceeding matters.

Co-chairs of the firm’s medical device group Sabing Lee and Salima Merani co-head the patent prosecution practice at Knobbe Martens Olson & Bear LLP , which is noted as being ‘beyond stellar’, from its office in Irvine, California. The team is well-versed on the full scope of patent law, from the development and management of portfolios in more transactional matters, to the contested and complex. The team handles patent counseling and prosecution, new product clearance and licensing, post grant proceedings and inter partes reviews, advising clients in industry sectors from technology to media and entertainment, with particular expertise in both life sciences and biotechnology evident across the practice, with high-value IP diligence work frequently completed for the likes of Cala Health. Terry Tullis and the ‘stand out’ Harnik Shukla, both regularly advise on some of the team’s most significant matters. ‘Detail-oriented’ Sabrina Wang specializes in medical device and consumer product IP law.

Baker Botts L.L.P.‘s ‘solid’ team is led by New York-based intellectual specialist Robert Scheinfeld and patent prosecution expert Sandra Lee , in addition to IP specialist Christa Brown-Sanford and experienced patent prosecution attorney Samir Bhavsar , both of whom work out of the Dallas office. The cohort has a strong reputation for its ability to develop and manage significant patent portfolios for notable clients across a range of industry sectors, namely education, technology and telecommunications, including Colombia University and Mastercard. A key example of such work is its current representation of Ericsson in the development and management of an international patent portfolio, directed to a wide range of technologies. The team is one of the most active in the US in terms of representing its clients at post-grant and inter-partes reviews filed at the PTAB, an example being its defense of the validity of Qualcomm’s patents in an action raised by Apple, with Palo Alto-based Eliot Williams particularly adept in this area. Additionally, Dallas’ Chad Walters, co-chair of the firm-wide PTAB trials group, is a key name for related litigation in the space.

The team at Morgan, Lewis & Bockius LLP, which has a bicoastal presence, is led by Philadelphia-based Louis Beardell and Silicon Valley-based Dion Bregman. The team handles matters spanning a broad array of industry sectors, including life sciences, automotive, consumer products and electrical, with standout work including advising on internet technologies which have developed as an indirect result of Covid-19, for such major clients as Walmart, a key relationship for partner Manita Rewat, who joined the Silicon Valley office from Duane Morris LLP in September 2022. Internal team changes have also significantly impacted the firm’s practice, notably the October 2022 promotions to partner of Silicon Valley-based patent prosecution and PTAB specialist Alexander B Stein, and Philadelphia-based Deping Chai, who is developing a specialism in international prosecution matters, particularly in the area of material sciences. Boston-based Stephen Altieri, noted as ‘outstanding’, has strong capabilities in advising emerging life sciences companies in particular.

Washington DC’s Matthew Wolf and Chicago’s Dina Hayes co-lead the practice at Arnold & Porter, which combines strategic advice to its clients and developing patent portfolios, with representing in key patent prosecution matters. The team is particularly renowned in the area of developing technology in the life sciences industry, an example being its work in the patent prosecution of transgenic plants for Bayer. It also acts for such notable clients as Finch Therapeutics and Regeneron in this field. DC-based senior associate Alice Ho is developing a particular specialism in prosecution, inter partes and ex parte matters involving biotech, medical devices, pharma and life sciences, while, also in DC, David Marsh has significant experience advising on the full range of IP matters. Silicon Valley’s Deborah Fishman is another name to note in the team, focusing on biopharma and medical devices litigation.

Haynes and Boone, L.L.P. has a strong reputation for its abilities in the IP field, with a nationwide offering led by Alan Herda and David O’Dell in Dallas, New York's Richard Rochford, and  Washington DC-based Jeffrey Wolfson. The firm regularly acts for noteworthy clients in the medical devices and new technologies industries, including Paypal, Cisco and Twitter, advising on the full-range of matters, encompassing patent counseling, IP-related agreements and due diligence, and particularly regarded for its inter-partes review and re-examination work, a key example of which being its high-profile representation of medical device company Orthofix, Inc in its merging with Seaspine, wherein the team obtained two favorable rulings at the PTAB. Dallas-based David McCombs is renowned for his work at the PTAB and is the primary contact for many of the firm’s key clients, while  Austin’s Raghav Bajaj is also a key up-and-coming name for PTAB and inter-partes proceedings.

Silicon Valley-based intellectual property head William Gaede, Chicago-based patent prosecution head Ahsan Shaikh, who leads on a number of the team’s prominent matters, and Boston-based IP transactions and licensing head Edward Gordon , are key leaders of the team at McDermott Will & Emery LLP, with Silicon Valley’s Judy Mohr particularly focused on pharmaceutical and medical device matters, developing and defending portfolios for clients in these industries. The team continues to represent major clients such as Meta and related platforms, Panasonic and EA, with Boston’s Jenny Chen and Michael Siekman leading on key matters, an example being the multi-jurisdictional life sciences patent prosecution matter regarding a number of CRISPR Therapeutics’ lead programs. Partner Margaret Sampson notably joined the team in Austin, Texas from Baker Botts L.L.P. in July 2022.

Mark Tidman leads the intellectual property team from BakerHostetler‘s Washington DC office, with the practice focusing heavily on the tech, energy, and life sciences sectors. The team represents such significant clients as Meta and Amazon on IP-related matters, with Meta a key client for Atlanta-based partner Cory Davis, who advises on their cross-jurisdictional patent inventory related to the Metaverse. Denver-based partner Timothy Worrall specializes in life science work, having developed, filed and prosecuted the high-value international patent portfolio for Monjuvi, a novel cancer treatment approved for treatment of lymphoma. There have been significant team changes, with the joining of partners Michael Dreznes and Mark Itri in Costa Mesa from Morgan, Lewis & Bockius LLP in early 2022. Further, specialist counsels Kyle Morse and Duane Carver Jr. joined the New York City and Dallas teams respectively, in August 2022; both formerly worked at Dentons. Departures include Hussein Akhavannik in July 2022 and Kenneth J. Sheehan in June 2022 .

Choate, Hall & Stewart‘s Boston-based team is led by Charles Lyon, Brian Reese and Kristen Buteau, who offer expertise in patent-related life sciences work; alongside Charles Lyon, Brenda Herschbach Jarrell chairs the firm’s life sciences group, advising a broad array of companies, from clinical candidates to well-established organizations and institutions on biotech, pharmaceutical, and specialty chemical matters in particular. Atop its solid prosecution work, the team has a strong reputation for its post-grant and re-examination practice, with partner Stephanie Schonewald having handled a significant number of such matters at the PTAB.

Dechert LLP‘s Boston-based practice is co-led by Andrea Reid and Andrew Wilkins, who is described as ‘one of the best IP counsel’. The team is adept at advising on prosecution in a multitude of areas, though there is an evident expertise across the board in biotech, with the team being noted as a ‘terrific partner when it comes to new technologies’. Additionally, its work in life sciences and pharmaceuticals is noteworthy, a key example being Reid and the ‘business-centric’ and ‘excellent’ Chad Davis representing AVEO Oncology on the $566m multi-jurisdictional creation of its patent portfolio following its acquisition by LG Chem. Scott Warren  left the firm in August 2022.

Brian Ho in San Francisco and Dallas's Robert Hanson  co-lead the practice at Dentons, with support from the global chair of intellectual and tech Monica Richman in New York. The team advises a list of noteworthy clients, including a multitude of universities across the nation, for whom it consistently advises on patent prosecutions in life sciences and biotechnology matters. Additionally, the team has significant experience in the realm of developing technologies, including the likes of LG Electronics and Solidia Technologies, managing patent portfolios at both a domestic and international level, as well as the full range of other patent-related matters. Stephanie Seidman in San Diego is a key member of the team with particular expertise in the bio-pharma industry. Specialist counsels Kyle Morse and Duane Carver Jr. both departed in August 2022.

The patent prosecution offering at DLA Piper LLP (US) is led by Boston-based patent prosecution national chair Larissa Bifano , described as ‘incredibly business-minded’; San Diego-based co-practice group leader Sean Cunningham ; and deputy practice group leader Gina Durham , who is based in San Francisco. The team has undergone significant change in 2022 since the arrival to the Philadelphia office of three specialized IP partners from Troutman Pepper in early 2022: health sciences specialist Raymond Miller; patent expert Joseph Helmsen, and N Nicole Endejann, who is adept in patent prosecution. Additionally, patent due diligence partner Melissa Harwood joined the Seattle team from Polsinelli PC in April 2022. Associate Joseph Wolfe, who assists on many of the team’s most complex matters, is a name to note.

Co-head of the global intellectual property practice at Eversheds Sutherland Peter Pappas co-leads the team from the Atlanta office, alongside Malvern Griffin, also based in Atlanta, and Austin-based Nash Zogaib. It is well-equipped to handle prosecution and portfolio strategy matters on behalf of its key clients as part of its full-service IP practice, with particular focus on developing technologies, wherein it advises such notable clients as Lumen Technologies, and is also noted for its cross-border capabilities. San Diego’s Christopher Bolten has a reputation for dealing with life sciences and medical device work, while Atlanta’s Daniel Warren is described as ’embodying practicality’, and Jeffrey Guise in San Diego is another name to note.

Morrison Foerster‘s ‘diverse’ team has experience in advising its clients on the full spectrum of patent counseling and prosecution services, with a significant focus on and expertise in related life sciences work for such well-known biotech organisations such as Genentech. It has bases across the country, with key name Jonathan Bockman heading the Washington DC team. The team is headed by specialist in crop protection and plant IP Michael Ward, who works from both San Francisco and Boston respectively. Palo Alto’s Catherine Polizzi leads on many of the team’s most significant matters and is noted as being ‘exceptional in her knowledge of complicated biopharmaceutical technologies’. Palo Alto’s Janet Xiao is described as ‘excellent’.